N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 3 ClinicalTrials.gov

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Sponsor: AbbVie • ClinicalTrials.gov ID: NCT06810505

Registry updated: 2026-10-09
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. The goals of the study are to evaluate adverse events and how well treatment of atogepant works compared to placebo (looks like the study treatment but contains no medicine) in preventing chronic migraine in participants between 12 and 17 years of age. Atogepant is a medicine currently approved in the United States and Europe for the preventive treatment of migraine in adult patients with migraine and is being studied for the preventative treatment of chronic migraine in participants between the ages of 12 and 17 years. Participants will be randomly assigned to one of the 2 groups to be treated with either atogepant or placebo. This study is double-blinded, which means that neither the patients nor the study doctors know who is given which study treatment. Approximately 420 participants 12 to 17 years of age with chronic migraine will be enrolled at approximately 70 sites across the world. Participants will receive oral tablets of atogepant or placebo once daily for 12 weeks and will be followed for 4 weeks. Participants will attend regular visits during the study at a hospital or clinic and the effects of treatment will be checked by completion of a daily diary, medical assessments, blood tests, checking for side effects, and completing questionnaires.

Interventions

  • Atogepant (Drug)
    Oral tablet
  • Placebo for Atogepant (Drug)
    Oral tablet

Eligibility criteria

Inclusion Criteria: * History of chronic migraine with or without aura consistent with a diagnosis according to the International Classification of Headache Disorders, 3rd Edition (ICHD-3) (2018) for at least 6 months as of Visit 1. * During the last 28 days of the screening/baseline period, and as per eDiary: * Participant must have completed the eDiary for a minimum of 20 out of 28 days. * Participant has \>= 15 headache days. * Participant has \>= 8 migraine days. Exclusion Criteria: * Clinically significant hypertension per investigator's judgment. * History of any clinically significant hematologic, endocrine, pulmonary, renal, hepatic, gastrointestinal, cardiovascular or neurologic disease.

Conditions

Chronic Migraine

Locations

  • Rehabilitation and Neurological Services /ID# 270782 — Huntsville, Alabama, United States
  • Preferred Research Partners - Fayetteville /ID# 270419 — Fayetteville, Arkansas, United States
  • Preferred Research Partners /ID# 270389 — Little Rock, Arkansas, United States
  • Advanced Research Center /ID# 270257 — Anaheim, California, United States
  • Neuro Pain Research Center /ID# 271048 — Fresno, California, United States
  • Alliance for Research Alliance for Wellness /ID# 270398 — Long Beach, California, United States
  • Excell Research /ID# 270258 — Oceanside, California, United States
  • Lumos Clinical Research Center /ID# 270582 — San Jose, California, United States
  • Sunwise Clinical Research /ID# 270431 — Walnut Creek, California, United States
  • Northwest Florida Clinical Research Group, LLC /ID# 270833 — Gulf Breeze, Florida, United States
  • Auzmer Research /ID# 271158 — Lakeland, Florida, United States
  • My Preferred Research /ID# 270312 — Miami, Florida, United States
  • Encore Medical Research - Weston /ID# 271139 — Weston, Florida, United States
  • Pediatric Neurology & Epilepsy Center Of Central Florida - Winter Park /ID# 275263 — Winter Park, Florida, United States
  • Deaconess Midtown Hospital /ID# 270572 — Evansville, Indiana, United States
  • Michigan Headache & Neurological Institute /ID# 270942 — Ann Arbor, Michigan, United States
  • Proven Endpoints LLC /ID# 270269 — Ridgeland, Mississippi, United States
  • Cct Research - Papillion Research Center /ID# 270393 — Papillion, Nebraska, United States
  • Healthy Perspectives - Innovate Mental Health Services /ID# 270847 — Nashua, New Hampshire, United States
  • Dent Neurologic Institute - Amherst /ID# 270260 — Amherst, New York, United States
  • Headache Wellness Center /ID# 270568 — Greensboro, North Carolina, United States
  • The Children's Hospital of Philadelphia /ID# 270842 — Philadelphia, Pennsylvania, United States
  • Frontier Clinical Research - Scottdale /ID# 270854 — Scottdale, Pennsylvania, United States
  • Frontier Clinical Research - Smithfield /ID# 270849 — Smithfield, Pennsylvania, United States
  • Access Clinical Trials Inc /ID# 270280 — Nashville, Tennessee, United States
  • UT Health Austin at Dell Childrens Neurology Clinic /ID# 270577 — Austin, Texas, United States
  • Earle Research /ID# 270424 — Houston, Texas, United States
  • Clinpoint Trials /ID# 270261 — Waxahachie, Texas, United States
  • Pantheon Clinical Research /ID# 270259 — Bountiful, Utah, United States
  • Alpine Research Organization - Clinton /ID# 276527 — Clinton, Utah, United States
  • Highland Clinical Research /ID# 270281 — Salt Lake City, Utah, United States
  • Frontier Clinical Research - Kingwood /ID# 271053 — Kingwood, West Virginia, United States
  • London Health Sciences Centre - Victoria Hospital & Children's Hospital /ID# 270659 — London, Ontario, Canada
  • McGill University Health Centre - Glen Site /ID# 270662 — Montreal, Quebec, Canada
  • Herlev Hospital /ID# 270482 — Herlev, Capital Region, Denmark
  • Regionshospitalet Godstrup /ID# 270481 — Herning, Central Jutland, Denmark
  • Semmelweis Egyetem /ID# 271219 — Budapest, Hungary
  • Rozsavolgyi Rendelo-Ceba Bt. /ID# 271500 — Budapest, Hungary
  • Fondazione IRCCS Istituto Neurologico Carlo Besta /ID# 270756 — Milan, Milano, Italy
  • Ospedale Pediatrico Bambino Gesu /ID# 270759 — Rome, Roma, Italy
  • Konan Medical Center /ID# 270486 — Kobe, Hyōgo, Japan
  • Umenotsuji Clinic /ID# 270484 — Kochi, Kochi, Japan
  • Tominaga Clinic - Osaka /ID# 270483 — Osaka, Osaka, Japan
  • Tokyo Headache Clinic /ID# 271610 — Shibuya-ku, Tokyo, Japan
  • Tokyo Medical University Hospital /ID# 270487 — Shinjuku-ku, Tokyo, Japan
  • Tendo Brain Clinic /ID# 271410 — Tendo-shi, Yamagata, Japan
  • Nagaseki Headache Clinic /ID# 271699 — Kai, Yamanashi, Japan
  • Tanaka Neurosurgery & Headache Clinic /ID# 271346 — Kagoshima, Japan
  • Canisius-Wilhelmina Ziekenhuis /ID# 270374 — Nijmegen, Gelderland, Netherlands
  • HagaZiekenhuis /ID# 270379 — The Hague, South Holland, Netherlands
  • Clinical Research Center Medic-R /ID# 270235 — Poznan, Greater Poland Voivodeship, Poland
  • Athleticomed Sp. z o.o /ID# 270243 — Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
  • Specjalistyczne Gabinety Sp. z o.o /ID# 270238 — Krakow, Lesser Poland Voivodeship, Poland
  • MIGRE Polskie Centrum Leczenia Migreny /ID# 270239 — Wroclaw, Lower Silesian Voivodeship, Poland
  • Oha-Med Sp. Z O.O /ID# 270242 — Warsaw, Masovian Voivodeship, Poland
  • Hospital da Luz /ID# 277991 — Lisbon, Lisbon District, Portugal
  • Unidade Local de Saude de Almada-Seixal, EPE /ID# 278092 — Almada, Setúbal District, Portugal
  • Unidade Local de Saude de Coimbra /ID# 277993 — Coimbra, Portugal
  • Unidade Local de Saude de Santa Maria /ID# 277997 — Lisbon, Portugal
  • Unidade Local de Saude de Santo Antonio /ID# 278090 — Porto, Portugal
  • Caribbean Medical Research Center Headlands /ID# 271300 — San Juan, Puerto Rico
  • Great Ormond Street Children's Hospital /ID# 271550 — London, Greater London, United Kingdom
  • Medway Maritime Hospital /ID# 271885 — Gillingham, Kent, United Kingdom
  • Royal Aberdeen Children's Hospital /ID# 271664 — Aberdeen, Scotland, United Kingdom
  • Leeds Teaching Hospitals NHS Trust /ID# 273449 — Leeds, West Yorkshire, United Kingdom
  • Stepping Hill Hospital-Stockport NHS foundation trust /ID# 271883 — Stockport, United Kingdom
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record